Renal Non-Clear Cell Carcinoma — Trials

Renal Non-Clear Cell Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

71 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 37
Recruiting: 15
Ph III recruiting: 0
Growth YoY: —
Industry share: 19%
Top sponsor: National Cancer Institute (NCI)
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (4)

clinicaltrialsPublishedShowing 1–4 of 4 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03793166	Immunotherapy With Nivolumab and Ipilimumab Followed by Nivolumab or Nivolumab With Cabozantinib for Patients With Advanced Kidney Cancer, The PDIGREE Study	active not recruiting	Phase 3	1,175	National Cancer Institute (NCI)NIH	2	Aug 31, 2026	clinicaltrials
NCT03055013	Nivolumab in Treating Patients With Localized Kidney Cancer Undergoing Nephrectomy	active not recruiting	Phase 3	819	National Cancer Institute (NCI)NIH	3	Aug 28, 2026